ReviewAge and liver transplantation
Introduction
The face of liver transplantation has changed in the last decades. Significant improvements have been achieved in terms of post-transplant survival and quality of life. The number of liver transplants performed each year increased up to 2005 in the United States[1], [2] and up to 2010 in Europe,[3], [4], [5], [6] before becoming relatively stable thereafter. The steady increase in donation after circulatory death (DCD) has contributed to the expansion of the donor pool. However, less stringent criteria in the selection of donation after brain death (DBD) donors along with a growing number of DCD donors has not covered the gap between the number of organs and the number of patients who could derive a benefit from transplantation.[7], [8], [9], [10] Due to this imbalance between donors and recipients, there is a clear incentive to push the age limits for donation in liver transplantation. Indeed, good results have been extensively reported with older DBD donors.[11], [12], [13] In the current context of organ shortage, the issue is not whether older donors should be used, rather how to use them and in which recipients.
In parallel with improvements in post-transplant results, more liberal policies have been adopted allowing transplantation as an option in recipients older than 65. The proportion of registrants older than 60 has already increased significantly in the United States and in Europe.[9], [10], [14] Age at registration will probably continue to increase as decompensated hepatitis C virus (HCV)-related cirrhosis represents a lower proportion of candidates, while non-alcoholic steatohepatitis (NASH) has become a leading indication for transplantation.[15], [16] Indeed, patients with decompensated cirrhosis or NASH-related hepatocellular carcinoma (HCC) tend to be older than patients with other causes of liver disease.[10], [17]
The aims of this review are to present and summarise data concerning trends in age at registration for liver transplantation according to different aetiologies, impact of aging in candidates for transplantation and recipients, impact of older donors, interactions between older donors and older recipients and how to optimise the management in this population. This review is based on both a systematic review of the literature and expert opinion.
Section snippets
Trends in epidemiology and corresponding trends in recipients age
The age of liver transplant recipients has increased steadily over the last 15 years in the United States and Europe (Fig. 1A,B). For instance, the proportion of liver transplant recipients aged 65 or more increased from 9% in 2002 to 20% in 2017 in the United States.2 In the Eurotransplant area, there has been a 16% increase in the number of liver transplant recipients aged 65 years or more between 2012 and 2016.6 Similar trends have been observed in the mean age of new registrants for
Aging of the normal liver
The functional impact of aging is less pronounced on the liver than on the kidney or the heart. However, several aspects of the mechanisms involved in aging of the normal liver are important to better understand why donor age matters in liver transplantation.
As the liver ages, it tends to shrink in size with a 20 to 40% volume reduction, more marked in women than in men (Fig. 3). The hepatic arteriolar walls are thicker with a reduction in the endothelial cell fenestration and a decrease in
Lessons learned from kidney transplantation
Because of an organ shortage in kidney transplantation, there has been a trend towards the use of older donors, although it has become evident that kidneys from older donors have reduced functional reserve and graft survival.124 Because older recipients have shorter life expectancy than younger recipients and frequently die with a functional graft, transplant nephrologists have proposed allocation policies including age matching.[125], [126] The aim is to allocate the highest quality grafts to
Age matching between donors and recipients in liver transplantation: A complex issue
The scenario in liver transplantation is much more complex than in kidney transplantation since aging of the liver has less functional consequences. In addition, by contrast to patients with end-stage renal diseases who can be placed on dialysis, no effective artificial liver support exists. So far, in contrast to kidney transplantation, no allocation policy including age matching has been implemented for liver transplantation. Even though good results can be achieved by using old donors in
Conclusions
There is no universal age limit for transplantation but physiological condition including frailty and comorbidities are important to consider in older candidates. Efforts should be made to identify combinations of age, comorbidities and frailty that reduce transplant benefit in older recipients up to the point that transplantation may be futile.
In parallel, the cohort of elderly patients who were transplanted 1 to 3 decades ago is growing and these patients are mainly exposed to non-liver
Financial support
The authors received no financial support to produce this manuscript.
Conflicts of interest
The authors declare no conflicts of interest that pertain to this work.
Please refer to the accompanying ICMJE disclosure forms for further details.
Acknowledgments
The authors are indebted to Dr Vincent Karam who provided ELTR data on donors and recipient’s age in Europe
References (141)
- et al.
OPTN/SRTR 2011 Annual Data Report: liver
Am J Transplant
(2013) - et al.
Results of liver transplantation with donors older than 70 years: a case-control study
Transplant Proc
(2011) - et al.
Short-term results of liver transplantation with octogenarian donors
Transplant Proc
(2018) - et al.
Liver transplantation from donors aged 80 years and over: pushing the limit
Am J Transplant
(2004) - et al.
Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States
Gastroenterology
(2015) - et al.
Solid-organ transplantation in older adults: current status and future research
Am J Transplant
(2012) - et al.
The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition
J Hepatol
(2018) - et al.
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: a European study
J Hepatol
(2016) - et al.
Waiting list removal rates among patients with chronic and malignant liver diseases
Am J Transplant
(2006) - et al.
Recipient characteristics and morbidity and mortality after liver transplantation
J Hepatol
(2018)
Long-term probability of and mortality from de novo malignancy after liver transplantation
Gastroenterology
Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations
Am J Transplant
Frailty predicts waitlist mortality in liver transplant candidates
Am J Transplant
Physical frailty after liver transplantation
Am J Transplant
Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study
Am J Transplant
Impact of dialysis and older age on survival after liver transplantation
Am J Transplant
Nonchimeric HLA-identical renal transplant tolerance: regulatory immunophenotypic/genomic biomarkers
Am J Transplant
Comprehensive review on colorectal cancer and transplant
Am J Transplant
Lipotoxicity, overnutrition and energy metabolism in aging
Ageing Res Rev
Aging and liver regeneration
Trends Endocrinol Metab
HDAC1 cooperates with C/EBPalpha in the inhibition of liver proliferation in old mice
J Biol Chem
Ageing, telomeres, senescence, and liver injury
J Hepatol
Senescence in Health and Disease
Cell
Macrophage autophagy limits acute toxic liver injury in mice through down regulation of interleukin-1beta
J Hepatol
Senescence in chronic liver disease: is the future in aging?
J Hepatol
D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching
Am J Transplant
Donor age and outcome of liver transplantation
Hepatology
Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation
Am J Transplant
The Eurotransplant donor risk index in liver transplantation: ET-DRI
Am J Transplant
Characteristics associated with liver graft failure: the concept of a donor risk index
Am J Transplant
Donor factors predicting recipient survival after liver retransplantation: the retransplant donor risk index
Am J Transplant
Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients
Hepatology
Septuagenarian and octogenarian donors provide excellent liver grafts for transplantation
Transplant Proc
Donors older than 70 years in liver transplantation
Transplant Proc
Our experience in liver transplantation in patients over 65 yr of age
Clin Transplant
Long-term results of liver transplantation in older patients 60 years of age and older
Transplantation
The portrait of an adult liver transplant recipient in the United States from 1987 to 2013
JAMA Intern Med
Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C
N Engl J Med
Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy
Hepatology
Aging of liver transplant registrants and recipients: trends and impact on waitlist outcomes, post-transplantation outcomes, and transplant-related survival benefit
Gastroenterology
Sofosbuvir for previously untreated chronic hepatitis C infection
N Engl J Med
Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation
Gastroenterology
Race and disease etiology predict de novo malignancy risk following liver transplantation: insights for future individualized cancer screening guidance
Transplantation
Impact of hepatitis C virus (HCV) antiviral treatment on the need for liver transplantation (LT)
Liver Int
Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival
Liver Transpl
Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience
Liver Transpl
Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes
Transplantation
Cited by (178)
Perioperative Cardiovascular Risk Assessment and Management in Liver Transplant Recipients: A Review of the Literature Merging Guidelines and Interventions
2024, Journal of Cardiothoracic and Vascular AnesthesiaGeographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm!
2024, American Journal of TransplantationImmunosuppression for older liver transplant recipients
2024, Transplantation ReviewsAnalysis of the Survival of Patients Transplanted for Hepatocarcinoma According to Age at Transplantation
2023, Transplantation ProceedingsOlder liver grafts from donation after circulatory death are associated with impaired survival and higher incidence of biliary non-anastomotic structure
2023, Hepatobiliary and Pancreatic Diseases International